Radius Health
ProfileJobs

Radius Health

Suggest Edit
    • Healthbiotechdrug developmentpharma

    Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The Сompany's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging.

    Market capitalization(2018-04-20)
    $1.5 B
    Type
    Public
    HQ
    Waltham, US
    Founded
    2003
    Size (employees)
    229 (est)
    Website
    radiuspharm.com
    Radius Health was founded in 2003 and is headquartered in Waltham, US
    Report incorrect company information

    Key People/Management at Radius Health

    Michael Wyzga

    Michael Wyzga

    President & CEO
    Gary Hattersley

    Gary Hattersley

    Senior Vice President, Preclinical Development
    Michael Franken

    Michael Franken

    Senior Vice President, Chief Business Officer

    Radius Health Office Locations

    Radius Health has an office in Waltham
    Waltham, US (HQ)
    950 Winter St
    Show all (1)
    Report incorrect company information

    Radius Health Financials and Metrics

    Radius Health Financials

    USD

    Net income (FY, 2017)

    		(254.2 m)

    EBIT (FY, 2017)

    		(249 m)

    Market capitalization (20-Apr-2018)

    		1.5 b

    Cash (31-Dec-2017)

    		118.6 m

    EV

    		1.7 b
    Radius Health's current market capitalization is $1.5 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    General and administrative expense

    		77.5 m186.7 m

    R&D expense

    		107.4 m83.1 m

    Operating expense total

    		184.9 m269.8 m

    EBIT

    		(67.4 m)(59.4 m)(99.1 m)(184.9 m)(249 m)
    Quarterly
    USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Cost of goods sold

    		105 k

    General and administrative expense

    		6 m8.5 m13.6 m17.2 m19.2 m38.1 m50.1 m47.7 m

    R&D expense

    		16.3 m18.2 m27.5 m26.9 m27.5 m19.5 m19.7 m21 m

    Operating expense total

    		22.3 m26.7 m41.1 m44.1 m46.7 m57.6 m69.8 m68.7 m
    show all
    Annual
    USDFY, 2013FY, 2016FY, 2017

    Cash

    		12.3 m258.6 m118.6 m

    Accounts Receivable

    		28.3 m4.4 m

    Inventories

    		334 k2.3 m4.4 m

    Current Assets

    		12.6 m334.8 m269.5 m
    Quarterly
    USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Cash

    		104.4 m120.6 m198.6 m174.6 m135.1 m446.9 m

    Accounts Receivable

    		1.2 m11.7 m

    Inventories

    		1.6 m3.1 m

    Current Assets

    		440.1 m406.1 m373.5 m288.7 m223.6 m490.7 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		(60.7 m)(101.5 m)(182.8 m)(254.2 m)

    Depreciation and Amortization

    		27 k586 k2 m

    Inventories

    		1.7 m2.1 m7 m4.6 m(4.4 m)

    Accounts Payable

    		(250 k)2.3 m6.2 m(100 k)(2.2 m)
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

    Net Income

    		(23 m)(28.3 m)(40.5 m)(43.4 m)(46.2 m)(56.9 m)

    Accounts Payable

    		2.7 m279 k1.2 m1.3 m3.2 m3.3 m4.5 m3.8 m3 m2.7 m6.7 m
    show all
    USDY, 2017

    EV/EBIT

    		-6.7 x

    EV/CFO

    		-8.1 x

    Financial Leverage

    		1.9 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Vanda Pharmaceuticals
    Health - Public
    Mylan
    Health - Public
    Insys Therapeutics
    Health - Public
    Corcept Therapeutics
    Health - Public
    Compare competitors

    Radius Health News and Updates

    March 31, 2018

    Is Radius Health Worth Your Time?

    Report incorrect company information
    Download PDF